Beijing, China, August 11 2023 – Edge Medical's MP1000 multi-port endoscopic surgical robot received approval from the National Medical Products Administration (NMPA) of China. It is now authorized for use in urology, gynecology, general surgery, and thoracic surgery.
-This marks a significant milestone for Edge Medical's MP1000, as it expands its application from urology to multiple departments, becoming the first domestically developed brand of laparoscopic surgical robot to gain approval for use across various medical specialties. -This achievement signifies the dawn of a new era of comprehensive commercialization for Edge Medical's MP1000 since its initial approval in the field of urology in December 2022. -This breakthrough not only represents a pivotal moment in the history of Chinese brand surgical robots but also breaks the longstanding monopoly of foreign brand surgical robots. It holds great significance in rapidly advancing the clinical application of robotic surgery in China.
Kommentare